Cardiac fibrogenesis in magnesium deficiency: A role for circulating angiotensin II and aldosterone

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 1, 2006, Pages

  Sapna, S ^a   Ranjith, S K ^a   Shivakumar, K ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Cardiac fibroblasts; Magnesium deficient rats; Renin angiotensin aldosterone system

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; LOSARTAN; PROLINE; SPIRONOLACTONE; THYMIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FIBROBLAST; FIBROGENESIS; MAGNESIUM DEFICIENCY; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT;

ALDOSTERONE; ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; FIBROBLASTS; HEART VENTRICLES; MAGNESIUM DEFICIENCY; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RENIN;

EID: 33745712635     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01185.2005     Document Type: Article

References (32)

1. Altura BM and Altura BT. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. I. Clinical aspects. Magnesium 4: 226-244, 1985.
2. Altura BM and Altura BT. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. II. Experimental aspects. Magnesium 4: 245-271, 1985.
3. Bloom S. Magnesium deficiency cardiomyopathy. Am J Cardiovasc Pathol 2: 7-17, 1988.
4. Brugere MC, Nowacki W, Daveau M, Guex E, Linard C, Rock E, Lebreton J, Mazur A, and Rayssiguier Y. Inflammatory response following acute magnesium deficiency in the rat. Biochim Biophys Acta 1501: 91-98, 2000.
5. Dickens BF, Weglicki WB, Li YS, and Mak IT. Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS Lett 311: 187-191, 1992.
6. Dostal DE and Baker KM. The cardiac renin-angiotenisn system: conceptual, or a regulator of cardiac function? Circ Res 85: 643-650, 1999.
7. Gerling IC, Sun Y, Ahokas RA, Wodi LA, Bhattacharya SK, Warrington KJ, Postlethwaite AE, and Weber KT. Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype. Am J Physiol Heart Circ Physiol 285: H813-H821, 2003.
8. Grafe M, Auch-Schwelk W, Zakrzewicz A, Regitz-Zagrosek V, Bartsch P, Graf K, Loebe M, Gaehtgens P, and Fleck E. Angiotensin II-induced leukocute adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res 81: 804-811, 1997.
9. Heggtveit HA, Herman L, and Mishra RK. Cardiac necrosis and calcification in experimental magnesium deficiency: a light and electron microscopic study. Am J Pathol 45: 757-782, 1964.
10. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, and Coffman TM. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 92: 3521-3525, 1995.
11. Kumar BP and Shivakumar K. Depressed antioxidant defense in rat heart in experimental magnesium deficiency: implication for the pathogenesis of myocardial lesions. Biol Trace Elem Res 60: 139-144, 1997.
12. Kumar BP, Shivakumar K, and Kartha CC. Magnesium deficiency-related changes in lipid peroxidation and collagen metabolism in vivo in rat heart. Int J Biochem Cell Biol 29: 129-134, 1997.
13. Kumaran C and Shivakumar K. Calcium- and superoxide anion-mediated mitogenic action of substance P on cardiac fibroblasts. Am J Physiol Heart Circ Physiol 282: H1855-H1862, 2002.
14. Kumaran C and Shivakumar K. Superoxide-mediated activation of cardiac fibroblasts by serum factors in hypomagnesemia. Free Radic Biol Med 31: 882-886, 2001.
15. Laurant P, Dalle M, Berthelot A, and Rayssiguier Y. Time-course of the change in blood pressure level in magnesium-deficient Wistar rats. Br J Nutr 82: 243-251, 1999.
16. Pastore L, Tessitore A, Martinotti S, Toniato E, Alesse E, Bravi MC, Ferri C, Desideri G, Gulino A, and Santucci A. Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expressed by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 100: 1646-1652, 1999.
17. Perlini S. The potential advantage of omapatrilat: dual anti-fibrotic and anti-inflammatory effects in one single molecule. J Hypertens 23: 273-275, 2005.
18. Schlaich MP, Kaye DM, Lambert E, Hastings J, Lambert G, and Esler MD. Ang II and norepinephrine release: interaction and effects on the heart. J Hypertens 23: 1077-1082, 2005.
19. Seelig MS. Magnesium deficiency in the pathogenesis of disease. New York: Plenum, 1980, p. 186-204.
20. Shivakumar K. Model of cardiovascular injury in magnesium deficiency. Med Hypotheses 56: 110-113, 2001.
21. Shivakumar K and Kumar BP. Magnesium deficiency enhances oxidative stress and collagen synthesis in vivo in the aorta of rats. Int J Biochem Cell Biol 29: 1273-1278, 1997.
22. Shivakumar K and Kumaran C. Magnesium deficiency and cardiovasculat disease: molecular mechanisms and recent advances. In: Antioxidants and Cardiovascular Disease, edited by Nath R, Khullar M, and Singhal PK. New Delhi, India: Narosa, 2004, p. 180-197.
23. Shivakumar K, Dostal DE, Boheler K, Baker KM, and Lakatta EG. Differential response of cardiac fibroblasts from young adult and senescent rats to ANG II. Am J Physiol Heart Circ Physiol 284: H1454-H1459, 2003.
24. Somers MJ, Mavromatis K, Galis ZS, and Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 101: 1722-1728, 2000.
25. Touyz RM and Schiffrin EL. Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways. Hypertension 30: 222-229, 1997.
26. Turlapaty PD and Altura BM. Magnesium deficiency produces spasm of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science 208: 198-200, 1980.
27. Villarreal FJ, Kim NN, Ungab GD, Printz MP, and Dillmann WH. Identification of functional Ang II receptors on rat cardiac fibroblasts. Circulation 88: 2849-2861, 1993.
28. Weber KT, Sun Y, Katwa LC, and Cleutjens JP. Connective tissue: a metabolic entity? J Mol Cell Cardiol 27: 107-120, 1995.
29. Weglicki WB, Mak IT, and Phillips TM. Blockade of cardiac inflammation in magnesium deficiency by substance P receptor inhibition. Circ Res 74: 1009-1013, 1994.
30. Weglicki WB, Mak IT, Kramer JH, Dickens BF, Cassidy MM, Stafford RE, and Phillips TM. Role of free radicals and substance P in magnesium deficiency. Cardiovasc Res 31: 677-683, 1996.
31. Wu F, Altura BT, Gao J, Barbour RL, and Altura BM. Ferrylmyoglobin formation induced by acute magnesium deficiency in perfused rat heart causes cardiac failure. Biochim Biophys Acta 1225: 158-166, 1994.
32. Zhang H, Schmeisser A, Plotze K, Damme U, Mugge A, and Daniel WG. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADP/NADPH oxidases (Abstract). Circulation 96, Suppl 1: I287, 1997.